Reuters -- Swiss biotech group Actelion’s shares jumped 6.6 percent on Thursday on talk U.S. drugmaker Bristol-Myers Squibb (BMS) (BMY.N) may announce it holds more than 3 percent of the company.
Reuters -- Swiss biotech group Actelion’s shares jumped 6.6 percent on Thursday on talk U.S. drugmaker Bristol-Myers Squibb (BMS) (BMY.N) may announce it holds more than 3 percent of the company.
